SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinsk bioteknologi) "

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinsk bioteknologi)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Enroth, Stefan, et al. (författare)
  • Effects of Long-Term Storage Time and Original Sampling Month on Biobank Plasma Protein Concentrations
  • 2016
  • Ingår i: EBioMedicine. - 2352-3964. ; 12, s. 309-314
  • Tidskriftsartikel (refereegranskat)abstract
    • The quality of clinical biobank samples is crucial to their value for life sciences research. A number of factors related to the collection and storage of samples may affect the biomolecular composition. We have studied the effect of long-time freezer storage, chronological age at sampling, season and month of the year and on the abundance levels of 108 proteins in 380 plasma samples collected from 106 Swedish women. Storage time affected 18 proteins and explained 4.8–34.9% of the observed variance. Chronological age at sample collection after adjustment for storage-time affected 70 proteins and explained 1.1–33.5% of the variance. Seasonal variation had an effect on 15 proteins and month (number of sun hours) affected 36 proteins and explained up to 4.5% of the variance after adjustment for storage-time and age. The results show that freezer storage time and collection date (month and season) exerted similar effect sizes as age on the protein abundance levels. This implies that information on the sample handling history, in particular storage time, should be regarded as equally prominent covariates as age or gender and need to be included in epidemiological studies involving protein levels.
  •  
2.
  • Matar, Amal (författare)
  • Considering a Baby? Responsible Screening for the Future : Ethical and social implications for implementation and use of preconception expanded carrier screening in Sweden
  • 2019
  • Doktorsavhandling (övrigt vetenskapligt)abstract
    • Preconception expanded carrier screening is a novel technology that involves the offer of a screening test for many recessive diseases (via an expanded screening panel) to prospective parents, with no priori risk. Test positive couples have a number of reproductive choices; prenatal diagnosis and aborting affected fetus, IVF and preimplantation genetic diagnosis, sperm or ovum donation or simply accept the risk. The test had been piloted in studies and can potentially be implemented in Europe. Therefore, it seemed pertinent to evaluate stakeholders’ perspectives on ethical and social implications of implementing and using preconception ECS in Sweden.Two main stakeholders were examined; healthcare professionals and health policymaking experts, via a mix of qualitative methods for data collection and data analysis. In Study I, we employed in-depth interviews to collect data and content analysis to analyze it. In Studies III and IV, expert interviews were used to gather data while thematic analysis was utilized to interpret it. Furthermore, in Study II, an ethical concept namely; reproductive autonomy, was critically discussed within a setting that expects a couple to make a conjoint reproductive decision about preconception ECS, while each partner still upholds his or her individual autonomy.The main findings of the empirical studies (Studies I, III and IV) echo to a great extent the prevailing ethical and social debates associated with the novel technology. Respondents expressed concerns with reproductive autonomy, medicalization, prioritization of health resources, discrimination and long term societal changes. Furthermore, respondents emphasized the importance to observe Swedish values, such as human dignity, equality and solidarity, when assessing a preconception ECS program. In addition, they described practicalities of implementation and political considerations that are pertinent to the Swedish context. Finally, some respondents recognized the advantages of reduced suffering and decrease in fetal anomalies and abortion as a consequence of preconception ECS.Study II, proposed a notion of couple autonomy, where certain demands if met, a couple’s reproductive decision can be accepted by healthcare staff as autonomous.The findings, in this thesis, steer towards non implementation of preconception ECS in its current status within the publicly-funded healthcare system in Sweden. This is because healthcare providers and experts were of the opinion that it would not solve a medical need, threaten Swedish values and use up resources extensively.
  •  
3.
  •  
4.
  • Petzold, Martin, et al. (författare)
  • Towards an Ambient Assisted Living User Interaction Taxonomy
  • 2013
  • Ingår i: CHI '13 Extended Abstracts of the ACM International Conference on Human Factors in Computing Systems. - New York : ACM Press. - 9781450318990 ; , s. 49-54
  • Konferensbidrag (refereegranskat)abstract
    • Extensive research in the field of ambient assisted living (AAL) provides profound knowledge about the design of AAL systems. However, more generic design characteristics for user interaction have not been formalized for this domain yet. Thus, we propose to develop a domain specific taxonomy for the design of user interaction in AAL systems. We adopted a systematic taxonomy development approach that combines an empirical and a pseudo-conceptual strategy. Six co-researchers from different disciplines conduct the iterative research process. Next to AAL systems existing taxonomies in the field of human-computer interaction are analyzed following the Delphi method. In this paper we present our research process and preliminary results from the first iteration. The final taxonomy allows classification and should support the analysis of user interaction utilized in AAL systems. Furthermore, it can deal as a practical design guideline.
  •  
5.
  • Boiso, Samuel, et al. (författare)
  • RapidHIT for the purpose of stain analyses – An interrupted implementation
  • 2017
  • Ingår i: Forensic Science International. - : Elsevier. - 1875-1768 .- 1875-175X. ; 6:Supplement C, s. e589-e590
  • Tidskriftsartikel (refereegranskat)abstract
    • Rapid DNA instruments have in recent years been developed, enabling analysis of forensic samples with a minimum of human intervention. Initially intended for fast handling of reference samples, such as samples from suspects in booking suites, attention shifted to include crime scene samples. The aim of this study was to determine whether or not the RapidHIT System (IntegenX) is fit for crime scene samples. The first runs gave very poor results, which was found to be due to an incorrect firmware setting leading to no or just minute amounts of amplicons being injected for electrophoresis. After solving this problem, 28 full runs (seven samples each) applying NGM SElect Express were performed comprising various amounts of blood on cotton swabs. Six of the runs failed completely, four due to cartridge leakage and in two runs the PCR mix was not injected. For 155 samples with 1–5ÎŒL blood (volumes for which complete DNA profiles are expected), 119 samples (77%) gave complete DNA profiles. Among the most serious failures were incorrect allele calling and leakage of DNA extract or PCR product. Other general issues were failure to export results, anode motor breakdown and broken capillary array. Due to the encountered problems with software, hardware and cartridges, together with the low success rate, it was decided not to continue towards implementation of the RapidHIT System in casework.
  •  
6.
  •  
7.
  • Lind-Halldén, Christina, et al. (författare)
  • Genetic variation in the syntaxin-binding protein STXBP5 in type 1 von Willebrand disease patients
  • 2018
  • Ingår i: Thrombosis and Haemostasis. - : Georg Thieme Verlag. - 2567-689X. ; 118:8, s. 1382-1389
  • Tidskriftsartikel (refereegranskat)abstract
    • von Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, for example, VWF, ABO and STXBP5. Here, we comprehensively screen for STXBP5 variants and investigate their association with type 1 VWD in Swedish patients and controls. The coding region of the STXBP5 gene was re-sequenced in 107 type 1 VWD patients and the detected variants were genotyped in the type 1 VWD population and a Swedish control population (464 individuals). The functional effects of missense alleles were predicted in silico and the pattern of genetic variation in STXBP5 was analysed. Re-sequencing of 107 type 1 VWD patients identified three missense and three synonymous variants in the coding sequence of STXBP5. The low-frequency missense variants rs144099092 (0.005) and rs148830578 (0.029) were predicted to be damaging, but were not accumulated in patients. No other rare candidate mutations were detected. STXBP5 showed a high level of linkage disequilibrium and a low overall nucleotide diversity of π = 3.2 × 10-4 indicating intolerance to variants affecting protein function. Three previously type 1 VWD-associated single nucleotide polymorphisms were located on one haplotype that showed an increased frequency in patients versus controls. No differences in messenger ribonucleic acid abundance among haplotypes could be found using Genotype-Tissue Expression project data. In conclusion, a haplotype containing the STXBP5 Asn436Ser (rs1039084) mutation is associated with type 1 VWD and no rare STXBP5 mutations contribute to type 1 VWD in the Swedish population.
  •  
8.
  • Altai, Mohamed, et al. (författare)
  • Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re.
  • 2014
  • Ingår i: European Journal of Medicinal Chemistry. - 0223-5234 .- 1768-3254. ; 87, s. 519-28
  • Tidskriftsartikel (refereegranskat)abstract
    • Affibody molecules constitute a class of small (7 kDa) scaffold proteins that can be engineered to have excellent tumor targeting properties. High reabsorption in kidneys complicates development of affibody molecules for radionuclide therapy. In this study, we evaluated the influence of the composition of cysteine-containing C-terminal peptide-based chelators on the biodistribution and renal retention of (188)Re-labeled anti-HER2 affibody molecules. Biodistribution of affibody molecules containing GGXC or GXGC peptide chelators (where X is G, S, E or K) was compared with biodistribution of a parental affibody molecule ZHER2:2395 having a KVDC peptide chelator. All constructs retained low picomolar affinity to HER2-expressing cells after labeling. The biodistribution of all (188)Re-labeled affibody molecules was in general comparable, with the main observed difference found in the uptake and retention of radioactivity in excretory organs. The (188)Re-ZHER2:V2 affibody molecule with a GGGC chelator provided the lowest uptake in all organs and tissues. The renal retention of (188)Re-ZHER2:V2 (3.1 ± 0.5 %ID/g at 4 h after injection) was 55-fold lower than retention of the parental (188)Re-ZHER2:2395 (172 ± 32 %ID/g). We show that engineering of cysteine-containing peptide-based chelators can be used for significant improvement of biodistribution of (188)Re-labeled scaffold proteins, particularly reduction of their uptake in excretory organs.
  •  
9.
  • Yu, Feifan, et al. (författare)
  • An affibody-adalimumab hybrid blocks combined IL-6 and TNF-triggered serum amyloid A secretion in vivo
  • 2014
  • Ingår i: MABS. - 1942-0862. ; 6:6, s. 1598-1607
  • Tidskriftsartikel (refereegranskat)abstract
    • In inflammatory disease conditions, the regulation of the cytokine system is impaired, leading to tissue damages. Here, we used protein engineering to develop biologicals suitable for blocking a combination of inflammation driving cytokines by a single construct. From a set of interleukin (IL)-6-binding affibody molecules selected by phage display, five variants with a capability of blocking the interaction between complexes of soluble IL-6 receptor a (sIL-6R alpha) and IL6 and the co-receptor gp130 were identified. In cell assays designed to analyze any blocking capacity of the classical or the alternative (trans) signaling IL-6 pathways, one variant, Z(IL-6_13) with an affinity (K-D) for IL-6 of similar to 500 pM, showed the best performance. To construct fusion proteins ("AffiMabs") with dual cytokine specificities, Z(IL-6_13) was fused to either the N-or C-terminus of both the heavy and light chains of the anti-tumor necrosis factor (TNF) monoclonal antibody adalimumab (Humira (R)). One AffiMab construct with Z(IL-6_13) positioned at the N-terminus of the heavy chain, denoted Z(IL-6_13)-HCAda, was determined to be the most optimal, and it was subsequently evaluated in an acute Serum Amyloid A (SAA) model in mice. Administration of the AffiMab or adalimumab prior to challenge with a mix of IL-6 and TNF reduced the levels of serum SAA in a dose-dependent manner. Interestingly, the highest dose (70 mg/kg body weight) of adalimumab only resulted in a 50% reduction of SAA-levels, whereas the corresponding dose of the Z(IL-6_13)-HCAda AffiMab with combined IL-6/TNF specificity, resulted in SAA levels below the detection limit.
  •  
10.
  • Lind-Halldén, Christina, et al. (författare)
  • Genetic variation in the syntaxin-binding protein STXBP5 in type 1 von Willebrand disease patients
  • 2018
  • Ingår i: Thrombosis and haemostasis. - 2567-689X. ; 118:8, s. 1382-1389
  • Tidskriftsartikel (refereegranskat)abstract
    • von Willebrand factor (VWF) levels in healthy individuals and in patients with type 1 von Willebrand disease (VWD) are influenced by genetic variation in several genes, for example, VWF, ABO and STXBP5. Here, we comprehensively screen for STXBP5 variants and investigate their association with type 1 VWD in Swedish patients and controls. The coding region of the STXBP5 gene was re-sequenced in 107 type 1 VWD patients and the detected variants were genotyped in the type 1 VWD population and a Swedish control population (464 individuals). The functional effects of missense alleles were predicted in silico and the pattern of genetic variation in STXBP5 was analysed. Re-sequencing of 107 type 1 VWD patients identified three missense and three synonymous variants in the coding sequence of STXBP5. The low-frequency missense variants rs144099092 (0.005) and rs148830578 (0.029) were predicted to be damaging, but were not accumulated in patients. No other rare candidate mutations were detected. STXBP5 showed a high level of linkage disequilibrium and a low overall nucleotide diversity of π = 3.2 × 10-4 indicating intolerance to variants affecting protein function. Three previously type 1 VWD-associated single nucleotide polymorphisms were located on one haplotype that showed an increased frequency in patients versus controls. No differences in messenger ribonucleic acid abundance among haplotypes could be found using Genotype-Tissue Expression project data. In conclusion, a haplotype containing the STXBP5 Asn436Ser (rs1039084) mutation is associated with type 1 VWD and no rare STXBP5 mutations contribute to type 1 VWD in the Swedish population.
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (3872)
konferensbidrag (532)
doktorsavhandling (440)
forskningsöversikt (209)
annan publikation (203)
bokkapitel (97)
visa fler...
licentiatavhandling (31)
patent (16)
rapport (15)
bok (6)
recension (4)
samlingsverk (redaktörskap) (3)
konstnärligt arbete (3)
proceedings (redaktörskap) (1)
visa färre...
Typ av innehåll
refereegranskat (4338)
övrigt vetenskapligt (1041)
populärvet., debatt m.m. (49)
Författare/redaktör
Thomsen, Peter, 1953 (243)
Palmquist, Anders, 1 ... (114)
Engqvist, Håkan (109)
Esposito, Marco, 196 ... (102)
Omar, Omar (82)
Uhlén, Mathias (80)
visa fler...
Hansson, Gunnar C., ... (69)
Persson, Cecilia (66)
Emanuelsson, Lena, 1 ... (65)
Shah, Furqan A. (53)
Xia, Wei (52)
Nielsen, Jens B, 196 ... (47)
Nilsson, Peter (47)
Lausmaa, Jukka (39)
Brånemark, Rickard, ... (36)
Suska, Felicia, 1974 (36)
Lammi, Mikko, 1961- (36)
Landegren, Ulf (35)
Johansson, Anna, 196 ... (34)
Los, Marek Jan (32)
Tolmachev, Vladimir (31)
Karlsson, Niclas G., ... (30)
Sundström, Birgitta (28)
Trobos, Margarita, 1 ... (28)
Engqvist, Håkan, 197 ... (27)
Johansson, Jan (26)
Schwenk, Jochen M. (26)
Kamali-Moghaddam, Ma ... (26)
Löfblom, John (26)
Lindahl, Anders, 195 ... (25)
Isaksson, Hanna (25)
Thomsen, Peter (25)
Knutsson, Hans (24)
Rising, Anna (24)
Pontén, Fredrik (23)
Svensson, Sara, 1981 (23)
Orlova, Anna (22)
Hilborn, Jöns (22)
Stigbrand, T. (22)
Li, Jin-Ping (21)
Wittung-Stafshede, P ... (21)
Ståhl, Stefan (20)
Orešič, Matej, 1967- (20)
Gatenholm, Paul, 195 ... (19)
Johansson, A (19)
Lindecrantz, Kaj, 19 ... (19)
Nilsson, Bo (19)
Laurell, Thomas (19)
Nilsson, Mats (19)
Kingham, Paul J. (19)
visa färre...
Lärosäte
Uppsala universitet (1226)
Göteborgs universitet (1094)
Umeå universitet (707)
Kungliga Tekniska Högskolan (661)
Chalmers tekniska högskola (579)
Karolinska Institutet (517)
visa fler...
Lunds universitet (502)
Linköpings universitet (498)
Örebro universitet (230)
Stockholms universitet (204)
Malmö universitet (92)
Linnéuniversitetet (82)
Sveriges Lantbruksuniversitet (75)
RISE (69)
Karlstads universitet (65)
Högskolan i Skövde (39)
Högskolan i Borås (39)
Högskolan Kristianstad (28)
Jönköping University (23)
Mittuniversitetet (23)
Luleå tekniska universitet (18)
Mälardalens universitet (12)
Gymnastik- och idrottshögskolan (10)
Högskolan i Gävle (10)
Södertörns högskola (9)
Högskolan i Halmstad (8)
Högskolan Väst (5)
Högskolan Dalarna (4)
Röda Korsets Högskola (3)
Blekinge Tekniska Högskola (1)
VTI - Statens väg- och transportforskningsinstitut (1)
Sophiahemmet Högskola (1)
Marie Cederschiöld högskola (1)
visa färre...
Språk
Engelska (5383)
Svenska (41)
Kinesiska (2)
Tyska (1)
Ryska (1)
Finska (1)
visa fler...
Ungerska (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (5218)
Naturvetenskap (1065)
Teknik (539)
Lantbruksvetenskap (45)
Samhällsvetenskap (40)
Humaniora (11)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy